Letter to the Editor: Validation of MELD 3.0 scoring system in East Asian patients with cirrhosis awaiting liver transplantation
- PMID: 37036243
- DOI: 10.1097/LVT.0000000000000152
Letter to the Editor: Validation of MELD 3.0 scoring system in East Asian patients with cirrhosis awaiting liver transplantation
Comment in
-
Reply: Validation of MELD 3.0 scoring system in East Asian patients with cirrhosis awaiting liver transplantation.Liver Transpl. 2023 Nov 1;29(11):E38-E39. doi: 10.1097/LVT.0000000000000154. Epub 2023 Apr 11. Liver Transpl. 2023. PMID: 37036734 No abstract available.
Comment on
-
MELD 3.0: The Model for End-Stage Liver Disease Updated for the Modern Era.Gastroenterology. 2021 Dec;161(6):1887-1895.e4. doi: 10.1053/j.gastro.2021.08.050. Epub 2021 Sep 3. Gastroenterology. 2021. PMID: 34481845 Free PMC article.
References
-
- Kim WR, Mannalithara A, Heimbach JK, Kamath PS, Asrani SK, Biggins SW, et al. MELD 3.0: the Model for End-Stage Liver Disease updated for the modern era. Gastroenterology. 2021;161:1887–1895 e1884.
-
- Yoo JJ, Chang JI, Moon JE, Sinn DH, Kim SG, Kim YS. Validation of MELD 3.0 scoring system in East Asian patients with cirrhosis awaiting liver transplantation. Liver Transpl. 2023;29:1029–40.
-
- Kwong AJ, Zhang KY, Ebel N, Mannalithara A, Kim WR. MELD 3.0 for adolescent liver transplant candidates. Hepatology. 2023.
-
- Kim WR, Mannalithara A, Kwo PY, Bonham CA, Kwong A. Mortality in patients with end-stage liver disease above model for end-stage liver disease 3.0 of 40. Hepatology. 2023;77:851–861.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
